These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Neuroprotective effects of aldehyde dehydrogenase 2 activation in rotenone-induced cellular and animal models of parkinsonism. Chiu CC; Yeh TH; Lai SC; Wu-Chou YH; Chen CH; Mochly-Rosen D; Huang YC; Chen YJ; Chen CL; Chang YM; Wang HL; Lu CS Exp Neurol; 2015 Jan; 263():244-53. PubMed ID: 25263579 [TBL] [Abstract][Full Text] [Related]
7. Teleost Model as an Alternative in Parkinson's Disease. Manasa K; Chitra V; Tamilanban T Neurol India; 2020; 68(5):979-984. PubMed ID: 33109837 [TBL] [Abstract][Full Text] [Related]
8. Determinants of buildup of the toxic dopamine metabolite DOPAL in Parkinson's disease. Goldstein DS; Sullivan P; Holmes C; Miller GW; Alter S; Strong R; Mash DC; Kopin IJ; Sharabi Y J Neurochem; 2013 Sep; 126(5):591-603. PubMed ID: 23786406 [TBL] [Abstract][Full Text] [Related]
9. Complex I deficiency and dopaminergic neuronal cell loss in parkin-deficient zebrafish (Danio rerio). Flinn L; Mortiboys H; Volkmann K; Köster RW; Ingham PW; Bandmann O Brain; 2009 Jun; 132(Pt 6):1613-23. PubMed ID: 19439422 [TBL] [Abstract][Full Text] [Related]
10. Aldehyde dehydrogenase (ALDH) in Alzheimer's and Parkinson's disease. Grünblatt E; Riederer P J Neural Transm (Vienna); 2016 Feb; 123(2):83-90. PubMed ID: 25298080 [TBL] [Abstract][Full Text] [Related]
11. Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons. Dragicevic E; Poetschke C; Duda J; Schlaudraff F; Lammel S; Schiemann J; Fauler M; Hetzel A; Watanabe M; Lujan R; Malenka RC; Striessnig J; Liss B Brain; 2014 Aug; 137(Pt 8):2287-302. PubMed ID: 24934288 [TBL] [Abstract][Full Text] [Related]
13. Differential Alterations in Metabolism and Proteolysis-Related Proteins in Human Parkinson's Disease Substantia Nigra. Grünblatt E; Ruder J; Monoranu CM; Riederer P; Youdim MB; Mandel SA Neurotox Res; 2018 Apr; 33(3):560-568. PubMed ID: 29218503 [TBL] [Abstract][Full Text] [Related]
14. Aldehyde dehydrogenase 1 defines and protects a nigrostriatal dopaminergic neuron subpopulation. Liu G; Yu J; Ding J; Xie C; Sun L; Rudenko I; Zheng W; Sastry N; Luo J; Rudow G; Troncoso JC; Cai H J Clin Invest; 2014 Jul; 124(7):3032-46. PubMed ID: 24865427 [TBL] [Abstract][Full Text] [Related]
15. Neurodegeneration and motor dysfunction in mice lacking cytosolic and mitochondrial aldehyde dehydrogenases: implications for Parkinson's disease. Wey MC; Fernandez E; Martinez PA; Sullivan P; Goldstein DS; Strong R PLoS One; 2012; 7(2):e31522. PubMed ID: 22384032 [TBL] [Abstract][Full Text] [Related]
16. Aldehyde dehydrogenase variation enhances effect of pesticides associated with Parkinson disease. Fitzmaurice AG; Rhodes SL; Cockburn M; Ritz B; Bronstein JM Neurology; 2014 Feb; 82(5):419-26. PubMed ID: 24491970 [TBL] [Abstract][Full Text] [Related]
17. Gene expression profiling of sporadic Parkinson's disease substantia nigra pars compacta reveals impairment of ubiquitin-proteasome subunits, SKP1A, aldehyde dehydrogenase, and chaperone HSC-70. Mandel S; Grunblatt E; Riederer P; Amariglio N; Jacob-Hirsch J; Rechavi G; Youdim MB Ann N Y Acad Sci; 2005 Aug; 1053():356-75. PubMed ID: 16179542 [TBL] [Abstract][Full Text] [Related]
18. Decreased vesicular storage and aldehyde dehydrogenase activity in multiple system atrophy. Goldstein DS; Sullivan P; Holmes C; Kopin IJ; Sharabi Y; Mash DC Parkinsonism Relat Disord; 2015 Jun; 21(6):567-72. PubMed ID: 25829070 [TBL] [Abstract][Full Text] [Related]
19. Oxidation of dopamine to aminochrome as a mechanism for neurodegeneration of dopaminergic systems in Parkinson's disease. Possible neuroprotective role of DT-diaphorase. Graumann R; Paris I; Martinez-Alvarado P; Rumanque P; Perez-Pastene C; Cardenas SP; Marin P; Diaz-Grez F; Caviedes R; Caviedes P; Segura-Aguilar J Pol J Pharmacol; 2002; 54(6):573-9. PubMed ID: 12866711 [TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effect of IDPU (1-(7-imino-3-propyl-2,3-dihydrothiazolo [4,5-d]pyrimidin-6(7H)-yl)urea) in 6-OHDA induced rodent model of hemiparkinson's disease. Kumari N; Agrawal S; Kumari R; Sharma D; Luthra PM Neurosci Lett; 2018 May; 675():74-82. PubMed ID: 29567422 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]